OR WAIT null SECS
June 07, 2018
Vetter anounced the Open Innovation Challenge to examine the applicability of digital trends to injection systems.
June 06, 2018
Under the contract, AMRI will focus on the development and manufacture of APIs and drug product for Phase I clinical studies.
June 02, 2018
From separation systems to reactor technology, new tools are increasing the feasibility of continuous API production.
June 01, 2018
TxCell announces manufacturing agreement with Lonza for its HLA-A2 CAR-Treg cellular product.
Cambrex invests $5 million in new laboratory expansion at its Karlskoga, Sweden facility.
FUJIFILM Diosynth Biotechnologies opens Cambridge, MA center to promote collaboration with biotech companies.
Rentschler Fill Solutions and Ultragenyx announce fill and finish agreement for the US commercial supply of Mepsevii.
May 30, 2018
Rommelag will showcase its blow-fill-seal technology that collectively offers container production, aseptic filling, and container closure.
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
May 29, 2018
This marks the third FDA approval for the company’s second biomanufacturing plant in Incheon, Korea.